Drug Development

Clinical Trials Clinical Research Regulatory Affairs Weight Loss Drugs Obesity Treatments Market Competition Oncology AI in Healthcare Antiviral Drugs Cancer Treatment

7 ARTICLES

2d ago

Lilly Sues Six U.S. Firms Over Black‑Market Sales of Experimental Drug Retatrutide

The filings mark a broad effort to enlist courts, regulators and payment and shipping firms to stop unapproved sales that Lilly says put patients at risk

6 ARTICLES

4d ago

Bristol Myers Squibb to Build $2.3 Billion Modular Manufacturing Campus in Houston

3 ARTICLES

2w ago

Hilleman Laboratories to Produce rVSV Bundibugyo Ebola Vaccine Doses for Early Trials

12 ARTICLES

2w ago

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

11 ARTICLES

2w ago

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

4 ARTICLES

3w ago

Oral Antiviral Candidate Stops Measles-Like Virus Transmission in Ferret Study

6 ARTICLES

3w ago

Lilly Will Seek FDA Approval for Retatrutide in Q1 2027 After Two More Positive Phase 3 Trials

21 ARTICLES

3w ago

Novo Nordisk Sues Eli Lilly Over Alleged Misleading GLP‑1 Ads

10 ARTICLES

3w ago

Bristol Myers Squibb Buys Second NVIDIA DGX SuperPOD Built on Vera Rubin

3 ARTICLES

3w ago

Redwire Opens 30,000‑Square‑Foot Space Research and Manufacturing Center in Southern Indiana

31 ARTICLES

4w ago

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

5 ARTICLES

4w ago

Study Shows Epstein‑Barr Virus Provokes CD4+ T‑Cell Attack Linked to Multiple Sclerosis

3 ARTICLES

4w ago

Celtarys Launches Fluorescent Kit to Replace Radioactive Preclinical Assays

6 ARTICLES

4w ago

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

6 ARTICLES

last mo.

Lawmakers Demand Answers After Single Patient Received Experimental Eli Lilly Obesity Drug

3 ARTICLES

last mo.

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

Drug Development

Lilly Sues Six U.S. Firms Over Black‑Market Sales of Experimental Drug Retatrutide

Bristol Myers Squibb to Build $2.3 Billion Modular Manufacturing Campus in Houston

Hilleman Laboratories to Produce rVSV Bundibugyo Ebola Vaccine Doses for Early Trials

FDA Panel Rejects Deramiocel Cardiac Claim After Lancet Publishes HOPE‑3 Results

Argenx Agrees to Buy Forte Biosciences for $2.2 Billion

Oral Antiviral Candidate Stops Measles-Like Virus Transmission in Ferret Study

Lilly Will Seek FDA Approval for Retatrutide in Q1 2027 After Two More Positive Phase 3 Trials

Novo Nordisk Sues Eli Lilly Over Alleged Misleading GLP‑1 Ads

Bristol Myers Squibb Buys Second NVIDIA DGX SuperPOD Built on Vera Rubin

Redwire Opens 30,000‑Square‑Foot Space Research and Manufacturing Center in Southern Indiana

Never miss stories about

Drug Development

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

Study Shows Epstein‑Barr Virus Provokes CD4+ T‑Cell Attack Linked to Multiple Sclerosis

Celtarys Launches Fluorescent Kit to Replace Radioactive Preclinical Assays

Biogen's Tau Drug Cuts Brain Tau but Misses Dose‑Response Goal

Lawmakers Demand Answers After Single Patient Received Experimental Eli Lilly Obesity Drug

Sanofi Names Paulo Fontoura Global Head of R&D Pharma

Biogen to Buy RayThera for Up to $1 Billion

FulcrumSec Claims 1.3TB Theft From Novo Nordisk

Neumora Halts Navacaprant After Phase 3 KOASTAL Failures

Supreme Court Clears Path for Generic 'Skinny Labels' in Unanimous Hikma Ruling

Never miss stories about

Drug Development